Physician profile
Leon R Brill
NPI 1992762280
$3,453.95
in general payments reported to CMS, 2019-2025
14 companies · $653 in 2025
The $653 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,316 · 2021: $1,345 · 2022: $65.72 · 2023: $74.17 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $434 · Travel and Lodging: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.12 |
| Travel and Lodging | $292.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,315.00 | 2019-2021 | |
| Endo USA, INC. | $652.62 | 2025 | |
| Paragon 28, INC. | $145.28 | 2021 | |
| Melinta Therapeutics, LLC | $120.52 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $51.01 | 2023 | Jublia |
| Depuy Synthes Sales INC. | $30.69 | 2022 | |
| Kci USA, INC. | $26.73 | 2019 | |
| Kerecis Limited | $23.16 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Stryker Corporation | $20.89 | 2022 | |
| Smith+Nephew, INC. | $20.75 | 2019 | |
| Wright Medical Technology, INC. | $16.88 | 2019 | |
| Osiris Therapeutics INC. | $16.28 | 2019 | |
| Orthofix Medical, INC. | $14.14 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Brill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.